Fig. 3From: Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymomaSurvival probabilities for three molecular subgroups: OS (a) and PFS (b) in the recent cohort (1992–2014) and (c) OS in the entire cohort (1965–2014)Back to article page